CPT® Code 81238

The CPT® Code 81238 pertains to the analysis of the F9 gene, which is crucial for the production of coagulation factor IX, a protein that plays a vital role in the blood clotting process. This gene analysis is specifically designed to identify mutations within the full gene sequence of the F9 gene, which is located on the long (q) arm of the X chromosome at position 27.1. Coagulation factor IX is synthesized in the liver and remains inactive until it is needed for clot formation, particularly in response to injury. Upon activation by factor Xia, factor IX initiates a cascade of reactions involving various coagulation factors and molecules, ultimately leading to the sealing of damaged blood vessels and minimizing blood loss. The analysis of the F9 gene is particularly significant in the context of Hemophilia B, a bleeding disorder characterized by a deficiency of factor IX. This test can confirm a diagnosis of Hemophilia B in patients exhibiting symptoms such as spontaneous bleeding into joints or deep tissues, or it can be used to determine carrier status in females who have a family history of bleeding disorders but lack a known F9 genotype. The testing process involves obtaining a blood sample, which is then analyzed using polymerase chain reaction (PCR) amplification followed by fluorescent DNA full gene sequencing to detect any mutations present in the F9 gene.